Mindset Pharma Inc.: Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000
Mindset or the
Company ), a drug discovery and development company focused on developing next generation psychedelic medicines for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has closed an additional non-brokered private placement, pursuant to which the Company issued an aggregate of 2,021,187 units (a
Unit ) of the Company at a price of $0.40 per Unit (the
Offering Price ) for aggregate gross proceeds of $808,475 (the
Offering ). Inclusive of the brokered private placement that was completed by the Company on December 15, 2020, the Company has issued an aggregate of 12,500,000 Units for total gross proceeds of $5,000,000.
Mindset Pharma Inc.: Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing
Mindset or the
Company ), a drug discovery and development company focused on developing next generation psychedelic medicines for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has upsized and completed its previously announced brokered private placement, led by Mackie Research Capital Corporation, as sole agent and sole bookrunner (the
Agent ), pursuant to which the Company issued an aggregate of 10,428,813 units (a
Unit ) of the Company at a price of $0.40 per Unit (the
Offering Price ) for aggregate gross proceeds of $4,171,525.20, including the full exercise of the over-allotment option (the